Buckley Kohlhauff
Chief Tech/Sci/R&D Officer at NURIX THERAPEUTICS, INC.
Network origin in Buckley Kohlhauff first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 25 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Buckley Kohlhauff via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| Yale University | College/University | Undergraduate Degree Undergraduate Degree | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Baylor College of Medicine | College/University | Doctorate Degree Corporate Officer/Principal | |
| University of California San Diego | College/University | Undergraduate Degree Undergraduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Doctorate Degree | |
| LEXICON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder Director of Finance/CFO | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Director of Finance/CFO Comptroller/Controller/Auditor | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Director/Board Member | |
| University of California | College/University | Corporate Officer/Principal | |
| ARGENX SE | Pharmaceuticals: Other | Director/Board Member | |
BIOMILQ, Inc.
 BIOMILQ, Inc. Miscellaneous Commercial ServicesCommercial Services BIOMILQ operates mother-cultured infant breast milk company. The company was founded by Leila Strickland and Michelle Egger and is headquartered in Durham, NC. | Miscellaneous Commercial Services | Chairman | |
| DERMIRA, INC. | Pharmaceuticals: Major | General Counsel | |
| Lak505, LLC | Corporate Officer/Principal | ||
Maverick Therapeutics, Inc.
 Maverick Therapeutics, Inc. BiotechnologyHealth Technology Maverick Therapeutics, Inc. operates as a preclinical stage biotech company. It develops a novel class of T cell- redirecting antibody therapeutics that have the potential to substantially broaden the range of targets and clinical applications to be used for this ultra-potent mechanism. The company was founded by Robert Dubridge and Patrick A. Baeuerle in 2016 and is headquartered in Brisbane, CA. | Biotechnology | Director/Board Member | |
| University of California, Berkeley | College/University | Undergraduate Degree | |
| ORIC PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
K36 Therapeutics, Inc.
 K36 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology K36 Therapeutics, Inc. develops small molecule therapeutics. The company is based in Cambridge, MA. The company was founded in 2021. The CEO is Terry Connolly. | Pharmaceuticals: Major | Director/Board Member | |
| ENLIVEN THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| HARPOON THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Kosan Biosciences, Inc.
 Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Hastings College | College/University | Graduate Degree | |
| The University of California, San Francisco | College/University | Doctorate Degree | |
| AMYRIS, INC. | Chemicals: Specialty | Corporate Officer/Principal | |
| C.R. BARD | Medical Specialties | General Counsel | |
| CURIS, INC. | Biotechnology | Director/Board Member | |
| DNAX Research, Inc. | Corporate Officer/Principal | ||
| ADAMAS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Human Resources Officer | |
| VIR BIOTECHNOLOGY, INC. | Biotechnology | Human Resources Officer | |
| SYNDAX PHARMACEUTICALS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| XENCOR, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| XOMA CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal | |
| PHARMACYCLICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
ACT Biotech, Inc.
 ACT Biotech, Inc. Pharmaceuticals: MajorHealth Technology ACT Biotech, Inc. operates as a biopharmaceutical company which develops and commercializes targeted oral cancer drugs. The company was founded on February 15, 2008 and is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| LOXO ONCOLOGY INC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Doctorate Degree | |
Amphivena Therapeutics, Inc.
 Amphivena Therapeutics, Inc. Drugstore ChainsRetail Trade Amphivena Therapeutics, Inc. provides drug discovery services. It develops tetravalent, T-cell redirecting bispecific antibodies for the treatment of hematologic malignancies. The firm’s’ lead drug candidate is AMV-564, a CD33/CD3-targeting treatment for acute myeloid leukemia (AML), which Amphivena is currently preparing to advance into clinical development. The company was founded by Jeanmarie Guenot in December 2012 and is headquartered in San Francisco, CA. | Drugstore Chains | Director/Board Member | |
| The University of Colorado | College/University | Undergraduate Degree | |
Rainier Therapeutics, Inc.
 Rainier Therapeutics, Inc. BiotechnologyHealth Technology Rainier Therapeutics, Inc. operates as a biotechnology company that develops a targeted biologic for the potential treatment of metastatic bladder cancer. It provides Vofatamab, an antibody that is focused on the fibroblast growth factor of bladder and other cancer. The company was founded by Stephen Lau and is headquartered in San Leandro, CA. | Biotechnology | Director/Board Member | |
Inbiomotion SL
 Inbiomotion SL Medical SpecialtiesHealth Technology Inbiomotion SL designs and develops diagnostic assays. It focus on genetic biomarkers, which predict the bone-specific metastases in cancer patients. The firm develops biomarker in breast cancer primary tumors for predicting the bone relapse. The company was founded by in 2010 and is headquartered in Barcelona, Spain. | Medical Specialties | Director/Board Member | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree |
Statistics
International
| United States | 49 |
| Netherlands | 2 |
| Spain | 2 |
Sectoral
| Health Technology | 33 |
| Consumer Services | 11 |
| Commercial Services | 4 |
| Process Industries | 2 |
| Retail Trade | 2 |
Operational
| Director/Board Member | 70 |
| Corporate Officer/Principal | 45 |
| Independent Dir/Board Member | 31 |
| Undergraduate Degree | 18 |
| Chief Tech/Sci/R&D Officer | 14 |
Most connected contacts
| Insiders | |
|---|---|
| Lori Kunkel | 27 |
| Julia Gregory | 22 |
| Judith Reinsdorf | 18 |
| Clay Siegall | 18 |
| Jeffrey Tong | 16 |
| David Lacey | 12 |
| Jason Daniel Kantor | 11 |
| Eric C. Schlezinger | 10 |
| Christine Ring | 10 |
| Stefani Wolff | 8 |
| Edward Saltzman | 7 |
| Arthur Sands | 6 |
| Michael T. Lotze | 6 |
| Hans van Houte | 6 |
| Michael Mischke-Reeds | 6 |
- Stock Market
- Insiders
- Buckley Kohlhauff
- Company connections
